JIR
PRVA icon

James Investment Research’s Privia Health PRVA Stock Holding History

James Investment Research’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,581
Closed -$44K – 469
2023
Q1 		$44K Buy
+1,581
New +$41.7K 0.01% 373

Other funds holding PRVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

James Investment Research's PRVA Position: Q2 2023 in Review

James Investment Research sold out of Privia Health (PRVA) in Q2 2023, closing a stake of 1,581 shares — an estimated $44K sold.

James Investment Research first reported a position in PRVA in Q1 2023 and held it in 1 quarter. The position peaked at $44K in Q1 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • James Investment Research reported no remaining Privia Health position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 1,581 Privia Health shares in Q2 2023, an estimated $44K.
  • James Investment Research first reported a position in Privia Health in Q1 2023 and held it in 1 quarter.
  • James Investment Research's Privia Health position peaked at $44K in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.